ghk-cu injection human clinical trial FDA scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR ghk-cu injection safety clinical trial

Tirzepatide has been shown in clinical trials to significantly reduce visceral fatthe harmful fat stored around organs in the abdomen, which contributes to metabolic diseases like type 2 diabetes and cardiovascular disease, while also being influenced by human growth hormone levels

In a placebo-controlled trial in 34 healthy individuals, consuming yogurt fortified with 10 billion CFUs of Bifidobacterium animalis subspecies lactis plus 600 mg of the amino acid arginine (a precursor to nitric oxide) daily for 12 weeks improved vascular function and was therefore suggested to reduce atherosclerosis risk

While consumers are using less water to accomplish their household and cleaning tasks, which is beneficial from a climate perspective, they continue to use the same amount of soap and cleaning products

A 2025 Stanford Medicine study identifying a naturally occurring peptide that suppressed appetite and reduced body weight without the nausea and muscle loss associated with semaglutide confirmed what many clinicians had already observed: the GLP-1 mechanism is powerful, but it carries side effects tied directly to how it works

They are often used in medical settings to address specific health needs, such as boosting the immune system, supporting wound healing, and addressing deficiencies